Six Months of Treatment with Risperidone May Be Associated with Nonsignificant Abnormalities of Liver Function Tests in Children and Adolescents: A Longitudinal, Observational Study from Turkey


Erdogan A., Karaman M. G. , Ozdemir E. , Yurteri N., Tufan A. E. , Kurcer M. A.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, cilt.20, ss.407-413, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 20 Konu: 5
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1089/cap.2009.0113
  • Dergi Adı: JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
  • Sayfa Sayıları: ss.407-413

Özet

Objective: Risperidone is a promising agent for the treatment of schizophrenia, Tourette's disorder, mood disorders, and disruptive behavior disorders in young populations. However, adverse effects of risperidone may take a long time to emerge. The objective of this study was to investigate the changes in the liver function tests (LFTs) associated with more than 6 months of risperidone treatment in children and adolescents.